People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other, Other Technology, Other Health Care, Biotechnology, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Grove Collaborative, Inc. | — | Other | Series D+ | $414.0M | $2.0B | 2020 |
| GB Group plc | — | Other Technology | Series D+ | $117.0M | $2.6B | 2021 |
| Moving Off Campus LLC | — | Other Technology | Seed | $2.5M | $57.9M | 2012 |
| Neovasc Inc | — | Other Health Care | Seed | $1.5M | $37.3M | 2009 |
| Aequus Pharmaceuticals Inc. | — | Biotechnology | Seed | $1.1M | $20.5M | 2016 |
| CDB Holdings, Inc. | — | Other | Pre-Seed | $585K | $2.1M | 2023 |
| fuseSPORT, Inc. | — | Other Technology | Pre-Seed | $285K | $12.1M | 2014 |
| Magna Special Situations Fund LLC | — | Investment Vehicle | Pre-Seed | $200K | $666K | 2024 |
| BirdieFire LLC | — | Other Technology | Pre-Seed | $180K | $7.6M | 2015 |
Chris Clark at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Clark on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Williams | 1 | 18 |
| Lee Hower | 1 | 10 |
| Tim Chang | 1 | 9 |
| Jeff Crowe | 1 | 9 |
| Mark Sugarman | 1 | 7 |
| Steven Rubin | 1 | 7 |
| Christopher Clark | 1 | 7 |
| Hamed Shahbazi | 1 | 6 |
| Erik Blachford | 1 | 6 |
| David Ward | 1 | 6 |
| William O'Neill | 1 | 4 |
| ANN FEHR | 1 | 4 |
| Doug Janzen | 1 | 4 |
| Nick Brown | 1 | 4 |
| PAUL GEYER | 1 | 3 |
| Jane Hsiao | 1 | 3 |
| Chris Dornfeld | 1 | 2 |
| Mark Sawyier | 1 | 2 |
| Fotios Plakogiannis | 1 | 2 |
| Ian Ball | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.